SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Karyopharm Therapeutics Announces Oral Presentation at the American College of Rheumatology on the Use of Selective Inhibitors of Nuclear Export (SINE) CRM1 Antagonists in Preclinical Models of Systemic Lupus Erythematosus (SLE)